Medicare Enrolled
Dr. Seth Strope, MD
Urology Physician · Fairview Heights, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Strope from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Strope?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Strope
Dr. Seth Strope is an urology physician in Fairview Heights, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Strope performed 13,138 Medicare services across 1,654 unique beneficiaries.
Between the years covered by Open Payments, Dr. Strope received a total of $22,734 from 54 pharmaceutical and/or device companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Strope is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in IL
$22,734 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,138
Medicare services
Top 8% in IL for urology physician
1,654
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~691 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
8,965 | $0 | $1 |
| BCG treatment for bladder cancer | 1,650 | $2 | $5 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
437 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
425 | $87 | $315 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
225 | $48 | $127 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
213 | $61 | $253 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
197 | $177 | $720 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 174 | $134 | $700 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
117 | $46 | $125 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
114 | $7 | $38 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $115 | $429 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
70 | $5 | $12 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
61 | $37 | $96 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
48 | $267 | $828 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
39 | $25 | $101 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
38 | $79 | $317 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
34 | $68 | $258 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $132 | $391 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
26 | $40 | $126 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
25 | $83 | $261 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
20 | $87 | $476 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
19 | $97 | $1,191 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
16 | $227 | $803 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
16 | $67 | $234 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
15 | $147 | $441 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
14 | $59 | $227 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
14 | $158 | $715 |
| CT scan of abdomen with and without contrast A CT scan of the abdomen performed both before and after the administration of contrast dye to provide detailed images of internal structures. |
14 | $172 | $707 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
13 | $93 | $664 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
13 | $23 | $381 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
11 | $48 | $179 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $101 | $268 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
70.5% medium
29.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,734
Total received (2018-2024)
Avg $3,248/year across 7 years
Top 10% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
266
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,149 (66.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,416 (28.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,169 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,846
2023
$1,813
2022
$1,813
2021
$898
2020
$1,789
2019
$6,318
2018
$8,256
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UROGEN PHARMA, INC.
$304
PROCEPT BioRobotics Corporation
$249
Ferring Pharmaceuticals Inc.
$241
Sumitomo Pharma America, Inc.
$141
Boston Scientific Corporation
$135
AstraZeneca Pharmaceuticals LP
$121
Merck Sharp & Dohme LLC
$116
PFIZER INC.
$94
Janssen Biotech, Inc.
$77
Dendreon Pharmaceuticals LLC
$73
SUN PHARMACEUTICAL INDUSTRIES INC.
$63
Calyxo, Inc.
$54
ABBVIE INC.
$43
Bayer Healthcare Pharmaceuticals Inc.
$35
Novartis Pharmaceuticals Corporation
$27
Axonics, Inc.
$22
Ambu Inc.
$22
Astellas Pharma US Inc
$16
ACCORD HEALTHCARE, INC.
$14
Top 3 companies account for 43.0% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$15,267
PFIZER INC.
$1,477
Boston Scientific Corporation
$512
Astellas Pharma US Inc
$422
Merck Sharp & Dohme LLC
$358
UROGEN PHARMA, INC.
$327
Sumitomo Pharma America, Inc.
$312
Janssen Biotech, Inc.
$310
AstraZeneca Pharmaceuticals LP
$289
PROCEPT BioRobotics Corporation
$249
Ferring Pharmaceuticals Inc.
$241
Myriad Genetic Laboratories, Inc.
$240
ACCORD HEALTHCARE, INC.
$238
KARL STORZ Endoscopy-America
$190
Dendreon Pharmaceuticals LLC
$155
Myovant Sciences Inc.
$151
C. R. Bard, Inc. & Subsidiaries
$131
Olympus America Inc.
$129
Rochester Medical Corporation
$125
Edwards Lifesciences Corporation
$119
Janssen Scientific Affairs, LLC
$109
Bayer HealthCare Pharmaceuticals Inc.
$105
BOSTON SCIENTIFIC CORPORATION
$102
Verity Pharmaceuticals Inc.
$93
Novartis Pharmaceuticals Corporation
$85
ABBVIE INC.
$74
Bayer Healthcare Pharmaceuticals Inc.
$70
Blue Earth Diagnostics Limited
$64
SUN PHARMACEUTICAL INDUSTRIES INC.
$63
TOLMAR Pharmaceuticals, Inc.
$59
Ethicon US, LLC
$57
Progenics Pharmaceuticals, Inc.
$56
Calyxo, Inc.
$54
Allergan Inc.
$50
AbbVie, Inc.
$46
Kowa Pharmaceuticals America, Inc.
$40
Amgen Inc.
$36
AbbVie Inc.
$31
UROVANT SCIENCES INC
$26
Foundation Medicine, Inc.
$25
NeoTract Inc.
$24
Axonics, Inc.
$22
Ambu Inc.
$22
UroGen Pharma, Inc.
$22
Cumberland Pharmaceuticals, Inc.
$22
Sun Pharmaceutical Industries Inc.
$21
Smith+Nephew, Inc.
$19
Travere Therapeutics, Inc.
$17
Cook Medical LLC
$15
Acerus Pharmaceuticals Corporation
$14
Clarus Therapeutics Inc.
$13
COLOPLAST CORP
$13
Allergan, Inc.
$12
Laborie Medical Technologies Corp.
$12
Top 3 companies account for 75.9% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · AQUABEAM SYSTEM · Altis · Axonics · Axumin · BOTOX · Balversa · Bard Urinary Drainage Bag · CALDOLOR · CAMCEVI · CUSTOM CONTRACT CAM UROLOGY · CVAC ASPIRATION SYSTEM · Cook Medical Stents · ELIGARD · ERLEADA · FOUNDATIONONE · Flex-X · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL - KIDNEY STONE DISEASE · GENERAL PAIN MANAGEMENT · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · Moses 550 DFL · Myrbetriq · Natesto · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · SEGLENTIS · STRATAFIX · STRAVIX PL · SpaceOAR VUE System - 10mL · TALZENNA · TOVIAZ · TRADE PROMO: SPIES FLEXC · Thiola · Trelstar · US DEFL · UroLift · XGEVA · XTANDI · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (67%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for urology physician in IL.
Geographic Context
Urology physicians within 10 mi
110
Per 100K population
43.2
County median income
$70,178
Nearest hospital
MEMORIAL HOSPITAL
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Strope is a mixed practice specialist, with above-average Medicare volume (top 8% in IL), with consulting-driven industry engagement in the top 10% of IL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Strope experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Strope performed 8,965 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Strope receive payments from pharmaceutical companies?
Yes. Dr. Strope received a total of $22,734 from 54 companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Strope's costs compare to other urology physicians in Fairview Heights?
Dr. Strope's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Strope) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fairview Heights
Browse urology physicians in Fairview Heights ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology